Adrenal cancer is rare enough that no single factor decides the right hospital, it takes three things together. First, pathology expertise that reliably tells this cancer apart from the far more common benign adrenal tumours. Second, a surgeon with real volume in this specific disease. Third, access to medical oncology for systemic therapy, since surgery alone frequently isn’t enough on its own. Rarity is exactly why all three matter.
According to Dr. Sandeep Nayak, Surgical Oncologist in India, “Adrenal cancer is genuinely uncommon, which changes what a good hospital needs to offer. A pathologist who sees enough of these to read them accurately, a surgeon who’s operated on more than a handful, and a team that can move to systemic therapy when surgery alone won’t be enough. Any one of those missing weakens the whole plan. This disease punishes centres that treat it as a routine adrenal case.”
Diagnosed with adrenal cancer and researching treatment centres?
What Should the Hospital Offer?
Three specific capabilities separate a genuinely equipped centre from one treating this as routine.
- Accurate pathology : Because adrenal cancer is rare and benign adenomas are common, a pathologist experienced with this specific distinction is essential, not optional.
- Surgical volume in this cancer : General adrenal surgery experience isn’t the same as experience with adrenocortical carcinoma specifically, which very few surgeons see often.
- Multidisciplinary access : A team that includes medical oncology, since adjuvant systemic therapy is frequently part of the plan, not a backup option.
- Complete resection focus : The surgery itself must aim for clear margins from the first attempt, since a second operation rarely recovers a compromised first one.
This combination underpins serious adrenal tumor treatment, where rarity makes every one of these elements count more than it would for a common cancer.
Why Does Rarity Change What Matters?
A cancer this uncommon puts pressure on parts of the system that common cancers don’t test.
- Few centres see enough : With such a low incidence, many hospitals encounter this cancer only occasionally, which limits how much genuine expertise they can build.
- Late diagnosis is common : This cancer is often found at a more advanced stage, which makes access to systemic therapy alongside surgery more frequently necessary.
- Systemic therapy has limits : Standard treatment beyond surgery has a modest response rate, so getting the surgical part right the first time carries extra weight.
- Coordination matters more : With surgery, pathology and medical oncology all playing a role, a centre where these teams actually work together beats one where they don’t.
Understanding how this cancer differs from the benign tumours it’s often confused with is covered in our guide on adrenal tumor management, the foundation for judging any centre’s approach.
Why Choose Dr. Sandeep Nayak for Adrenal Cancer Treatment?
Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. He has treated adrenocortical carcinoma alongside the far more common benign adrenal tumours, and works within a multidisciplinary framework where medical oncology input is available when surgery alone isn’t the complete answer. The approach treats this rare cancer’s specific demands seriously, from accurate diagnosis through to a complete first resection.
Adrenal cancer’s rarity is precisely why treatment can’t be left to chance. A centre with the pathology expertise to diagnose it correctly, the surgical experience to remove it completely, and the multidisciplinary access to add systemic therapy where needed gives a patient the coordinated approach this uncommon cancer demands. That combination, not any single factor alone, is what separates genuinely equipped adrenal cancer care from a routine attempt.
Frequently Asked Questions
What makes a hospital good for adrenal cancer treatment?
Accurate pathology, surgical volume with this rare cancer, and access to systemic therapy.
Why is pathology expertise so important here?
Adrenal cancer is rare, and misreading benign versus malignant changes the whole plan.
Does the hospital need more than a surgeon?
Yes. Since surgery alone often isn’t curative, access to medical oncology matters too.
Why does surgical volume matter for a rare cancer?
Few surgeons see enough cases to build real judgement in managing it well.
References
- Adrenocortical carcinoma incidence and survival outcomes — National Library of Medicine
- Advancing systemic treatment for adrenocortical carcinoma — National Library of Medicine
Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.
